HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel intronic polymorphisms in the presenilin-2 gene and a case-control association study of Alzheimer's disease.

Abstract
Several alleles of introns or untranslated regions in the presenilin-1 (PS-1) and presenilin-2 (PS-2) genes have been reported to behave as risk factors for senile Alzheimer's disease (AD). On the other hand, mutations in the three presenile AD genes also have been identified in a small number of sporadic presenile AD and senile AD cases. The present study evaluated the genetic contributions of PS-2 exons and introns to 56 senile and 18 Japanese cases of presenile AD using polymerase chain reaction single-strand conformation polymorphism analysis. In the PS-2 gene, one exonic polymorphic site without amino acid substitution, 9 intronic polymorphic sites, and 2 intronic variant sites were detected. However, in all cases, amino acid substitutions in exons between 4 and 12 of the PS-2 gene were not observed. The risk factors of senile and presenile AD were evaluated using a population-based study of restriction cleavages between patients and controls in introns 3, 4, 10 and 11. Regarding PS-2, there was no association between AD and intronic polymorphisms.
AuthorsM Honda, T Kaname, R Igata-Yi, T Igata, Y Hitoshi, K Ogomori, T Miyakawa, K I Yamamura
JournalPsychiatry and clinical neurosciences (Psychiatry Clin Neurosci) Vol. 53 Issue 5 Pg. 579-85 (Oct 1999) ISSN: 1323-1316 [Print] Australia
PMID10595683 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Membrane Proteins
  • PSEN2 protein, human
  • Presenilin-2
Topics
  • Alzheimer Disease (genetics)
  • Case-Control Studies
  • Exons (genetics)
  • Female
  • Humans
  • Introns (genetics)
  • Male
  • Membrane Proteins (genetics)
  • Middle Aged
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Polymorphism, Single-Stranded Conformational
  • Presenilin-2
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: